SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-20-009639
Filing Date
2020-04-24
Accepted
2020-04-24 08:55:35
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 nt10011234x1_s3.htm S-3 349774
2 EXHIBIT 4.9 nt10011234x1_ex4-9.htm EX-4.9 335120
3 EXHIBIT 5.1 nt10011234x1_ex5-1.htm EX-5.1 46390
4 EXHIBIT 23.1 nt10011234x1_ex23-1.htm EX-23.1 2229
5 EXHIBIT 25.1 nt10011234x1_ex25-1.htm EX-25.1 51335
6 logo_biocryst2a.jpg GRAPHIC 48001
7 logo_biocryst2ax1.jpg GRAPHIC 52875
8 nc10011234x1_ex5-1image1.jpg GRAPHIC 115120
9 nt10011234x1_ex25-1image01.jpg GRAPHIC 81951
10 nt10011234x1_ex25-1image02.jpg GRAPHIC 88087
  Complete submission text file 0001140361-20-009639.txt   1317457
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237820 | Film No.: 20812670
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences